About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Cause of Peripheral Neuropathy Suggests Preventive Measures

by Bidita Debnath on October 14, 2017 at 11:39 PM
Font : A-A+

Cause of Peripheral Neuropathy Suggests Preventive Measures

Peripheral neuropathy is a disorder of nerve(s) apart from the brain and spinal cord. Patients with peripheral neuropathy may have tingling, numbness, unusual sensations, weakness, or burning pain in the affected area.

In discovering how certain chemotherapy drugs cause peripheral neuropathy, researchers at Dana-Farber Cancer Institute have found a potential approach to preventing this common and troublesome side effect of cancer treatment.

Advertisement


The symptoms of peripheral neuropathy, which affects about one-third of patients receiving chemotherapy, include numbness, tingling, and pain in the hands and feet. Some patients get better after treatment ends, but in others the symptoms are long-lasting. There is currently no preventive or treatment for peripheral neuropathy, which is caused by the degeneration of the long, spindly nerve cell projections called axons that transmit physical sensations to the brain.

Unlike the brain, which is protected by a physical barrier from many harmful chemicals, nerve axons - which can extend as long as two or three feet in humans -- are exposed to substances that flow through the blood circulation. The new report in the journal Neuron reveals for the first time precisely how taxanes, a class of commonly used chemotherapy drugs, trigger a dying off of sensory axons. With this knowledge, it might someday be possible, the investigators say, to give patients a drug prior to chemotherapy treatment that would reduce or prevent neuropathy symptoms. Taxane drugs are routinely used in treating early-stage breast cancer, and some other cancer types.
Advertisement

Researchers led by Rosalind Segal, MD, PhD, discovered that a protein called Bclw plays a unique braking role in preventing the degeneration of nerve axons. Bclw blocks the action of another protein that sets off a cascade of chemical reactions ending in nerve cell death. Segal says that Bclw is part of a regulatory system that allows unnecessary nerves to be "pruned" or killed off during embryonic development. During adult life, Bclw protects nerves from degeneration - except in the case of a traumatic injury or, in cancer treatment, exposure to chemotherapy drugs.

The gene carrying the blueprint for Bclw is located in the nucleus of the nerve cell. A carrier protein, SFPQ, transports copies of the Bclw blueprint in the form of messenger RNA along the nerve axon, where the protective Bclw protein is manufactured.

Segal and her colleagues found that adding a taxane drug, paclitaxel, to sensory nerve axons in the laboratory dramatically impeded the transport of Bclw messenger RNA by the SFPQ protein. As a result, too little of the Bclw protein was made to protect the axons, and they degenerated.

This finding led the investigators to ask if adding Bclw protein to the nerve axons before exposing them to paclitaxel would prevent the nerves from dying off -- and it did. Moreover, they demonstrated that a synthetic compound based on a part of the Bclw protein - a so-called "stapled peptide" made in the laboratory of DFCI researcher Loren Walensky, MD, -- was able to prevent degeneration from exposure to paclitaxel. This "designer peptide provides a promising template for drugs that can prevent chemotherapy-induced peripheral neuropathy," say the scientists.

Such drugs aren't likely to become available any time soon, but Segal says having discovered the mechanism that causes peripheral neuropathy in patients treated with taxane chemotherapy might be valuable in other ways. "One possibility is that you might be able to predict which patients will develop peripheral neuropathy based on whether they have higher or lower levels of Bclw based on their genetic background."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Health Benefits of Giloy
Breast Cancer Awareness Month 2021 - It's time to RISE
First-Ever Successful Pig-To-Human Kidney Transplantation
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Peripheral Neuropathy 11 Alarming Symptoms & Signs You Should Look Out For Nerve Damage Drug-Induced Neuropathy Allodynia 

Recommended Reading
Vincristine Induced Peripheral Neuropathy Linked With Gene Variant in Children With Acute Lymphoblastic Leukemia
Children with acute lymphoblastic leukemia who had a certain gene variant experienced a higher ......
Cytotoxicity is a Risk Factor for Diabetic Peripheral Neuropathy
Iron overload can lead to cytotoxicity, which in turn is a risk factor for diabetic peripheral ......
Understanding of Peripheral Neuropathy Improved By Research
One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2). It is a condition ......
Link Between Obstructive Sleep Apnea and Diabetic Peripheral Neuropathy
In patients with type 2 diabetes, strong association exists between obstructive sleep apnea and ......
11 Alarming Symptoms & Signs You Should Look Out For Nerve Damage
Our nervous system is involved in numerous functions such as sensing touch and pain, breathing, dige...
Allodynia
Allodynia is a nerve condition where non-painful stimuli such as a light touch or brushing hair prov...
Drug-Induced Neuropathy
Some drugs which are prescribed to treat disease may cause neuropathy as an adverse effect. Signs an...
Peripheral Neuropathy
Peripheral neuropathy is a condition that causes weakness, numbness and pain, especially in the limb...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use